- ¥309bn
- ¥327bn
- ¥150bn
- 94
- 41
- 94
- 91
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | 12.99 | ||
PEG Ratio (f) | 3.05 | ||
EPS Growth (f) | 4.44% | ||
Dividend Yield (f) | 2.25% |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 2.84 | ||
Price to Tang. Book | 2.87 | ||
Price to Free Cashflow | 21.66 | ||
Price to Sales | 1.94 | ||
EV to EBITDA | 11 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 24.11% | ||
Return on Equity | 20.64% | ||
Operating Margin | 17.56% |
Financial Summary
Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | ¥m | 96,515 | 100,638 | 112,069 | 132,426 | 150,356 | 167,725 | 177,500 | 10.26% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | +58.88 | -0.1 | +16.88 | +39 | +47.05 | +32.28 | +4.44 | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
ORGANO CORPORATION is a Japan-based company mainly engaged in the water treatment engineering business and functional products business. The Company operates through two business segments. The Water Treatment Engineering segment is mainly engaged in the manufacture, sale, maintenance and management of filtration equipment, pure water system equipment and other water treatment related equipment. The Functional Product segment is mainly engaged in the manufacture and sale of standard water treatment equipment, water treatment chemicals and food additives. The Company is also engaged in the chemical plant construction business.
Directors
- Masaki Uchikura PRE (66)
- Masayuki Yamada SME (62)
- Hitoshi Hori MEO (63)
- Yasutoshi Nakayama MEO (60)
- Nobuyoshi Suda MEO (57)
- Shin Asano MEO
- Kazuhisa Fukuda MEO
- Makoto Tomizawa MEO
- Tetsushi Honda EXO (58)
- Fusayoshi Akimoto EXO
- Toru Amemiya EXO
- Shojiro Koike EXO
- Makoto Kukizaki EXO
- Tatsuya Kunieda EXO
- Katsumi Ohga EXO
- Ken Shimada EXO
- Koh Yoshida EXO
- Kenji Hirai IND (68)
- Motoo Nagai IND (67)
- Keiko Terui IND (68)
- Last Annual
- March 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- July 29th, 1941
- Public Since
- October 2nd, 1961
- No. of Shareholders
- 9,524
- No. of Employees
- 2,512
- Sector
- Professional & Commercial Services
- Industry
- Industrials
- Exchange
Tokyo Stock Exchange
- Shares in Issue
- 45,966,230

- Address
- 1-2-8, Shinsuna, KOTO-KU, 136-8631
- Web
- https://www.organo.co.jp/
- Phone
- +81 356355100
- Auditors
- KPMG AZSA LLC
Upcoming Events for 6368
Similar to 6368
Abist Co
Tokyo Stock Exchange
Accrete
Tokyo Stock Exchange
Aeon Delight Co
Tokyo Stock Exchange
AGENT
Tokyo Stock Exchange
Aidma Holdings
Tokyo Stock Exchange
FAQ
As of Today at 22:28 UTC, shares in Organo are trading at ¥6,760. This share price information is delayed by 15 minutes.
Shares in Organo last closed at ¥6,760 and the price had moved by -7.14% over the past 365 days. In terms of relative price strength the Organo share price has underperformed the Nikkei 225 Index by -2.14% over the past year.
The overall consensus recommendation for Organo is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreThe Organo dividend yield is 1.95% based on the trailing twelve month period.
Last year, Organo paid a total dividend of ¥132, and it currently has a trailing dividend yield of 1.95%.Looking ahead, the next dividend pay date is 2025-06-01.
We do not have data on when Organo is to next pay dividends. The historic dividend yield on Organo shares is currently 1.95%.
To buy shares in Organo you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of ¥6,760, shares in Organo had a market capitalisation of ¥309bn.
Here are the trading details for Organo:
- Country of listing: Japan
- Exchange: TYO
- Ticker Symbol: 6368
Based on an overall assessment of its quality, value and momentum Organo is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Organo is ¥9,872. That is 46.03% above the last closing price of ¥6,760.
Analysts covering Organo currently have a consensus Earnings Per Share (EPS) forecast of ¥498 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Organo. Over the past six months, its share price has outperformed the Nikkei 225 Index by +7.33%.
As of the last closing price of ¥6,760, shares in Organo were trading -8.25% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Organo PE ratio based on its reported earnings over the past 12 months is 12.99. The shares last closed at ¥6,760.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Organo's management team is headed by:
- Masaki Uchikura - PRE
- Masayuki Yamada - SME
- Hitoshi Hori - MEO
- Yasutoshi Nakayama - MEO
- Nobuyoshi Suda - MEO
- Shin Asano - MEO
- Kazuhisa Fukuda - MEO
- Makoto Tomizawa - MEO
- Tetsushi Honda - EXO
- Fusayoshi Akimoto - EXO
- Toru Amemiya - EXO
- Shojiro Koike - EXO
- Makoto Kukizaki - EXO
- Tatsuya Kunieda - EXO
- Katsumi Ohga - EXO
- Ken Shimada - EXO
- Koh Yoshida - EXO
- Kenji Hirai - IND
- Motoo Nagai - IND
- Keiko Terui - IND